InfuSystem Holdings, Inc. (NYSE:INFU) Receives Average Recommendation of “Buy” from Analysts

InfuSystem Holdings, Inc. (NYSE:INFU) has been given an average rating of “Buy” by the five ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, two have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $14.50.

Several research analysts recently commented on INFU shares. Roth Capital reaffirmed a “buy” rating and issued a $14.00 price target (up previously from $13.00) on shares of InfuSystem in a research note on Tuesday, November 4th. Zacks Research downgraded shares of InfuSystem from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Lake Street Capital assumed coverage on shares of InfuSystem in a research note on Monday, September 22nd. They set a “buy” rating and a $15.00 price target for the company.

InfuSystem Stock Performance

INFU stock opened at $9.20 on Monday. InfuSystem has a twelve month low of $4.61 and a twelve month high of $11.04. The firm has a market cap of $187.09 million, a price-to-earnings ratio of 153.36 and a beta of 1.71. The business’s fifty day simple moving average is $9.57 and its two-hundred day simple moving average is $8.58. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.

Institutional Investors Weigh In On InfuSystem

Institutional investors and hedge funds have recently bought and sold shares of the company. Hillsdale Investment Management Inc. purchased a new stake in shares of InfuSystem in the 3rd quarter worth $4,665,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of InfuSystem by 220.1% in the third quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock valued at $4,655,000 after acquiring an additional 308,974 shares in the last quarter. Ancora Advisors LLC bought a new stake in shares of InfuSystem in the third quarter valued at about $2,096,000. Teton Advisors LLC purchased a new stake in InfuSystem in the third quarter worth about $1,917,000. Finally, Truffle Hound Capital LLC bought a new position in InfuSystem during the 2nd quarter worth about $1,123,000. 71.13% of the stock is owned by institutional investors.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.